These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 498052)

  • 1. Endocrine profile in a patient with familial breast cancer: a case-control study.
    Lynch HT; Harris RE; Fishman J; Lynch JF; Marrero K; Maloney K
    Cancer; 1979 Nov; 44(5):1860-9. PubMed ID: 498052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
    Usuki S; Kondoh K; Kubo T
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrine changes before and after the menarche. I. Urinary excretion of estrogen, FSH and LH, and serum levels of progesterone, FSH and LH.
    Widholm O; Kantero RL; Axelson E; Johansson ED; Wide L
    Acta Obstet Gynecol Scand; 1974; 53(3):197-208. PubMed ID: 4367752
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma hormone profiles of young women at risk for familial breast cancer.
    Fishman J; Fukushima D; O'Connor J; Rosenfeld RS; Lynch HT; Lynch JF; Guirgis H; Maloney K
    Cancer Res; 1978 Nov; 38(11 Pt 2):4006-11. PubMed ID: 698948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal estrogen conjugation in women at risk for familial breast cancer at the periovulatory stage of the menstrual cycle.
    Fishman J; Bradlow HL; Fukushima DK; O'Connor J; Rosenfeld RS; Graepel GJ; Elston R; Lynch H
    Cancer Res; 1983 Apr; 43(4):1884-90. PubMed ID: 6831424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in the gonadotrophins, in the prolactin and in the sexual steroid levels throughout the normal menstrual cycle (author's transl)].
    Buvat J; Buvat-Herbaut M
    J Gynecol Obstet Biol Reprod (Paris); 1981; 10(2):99-108. PubMed ID: 6792269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB; Salvatierra AM; Romero C; Spitz IM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of urinary and plasma hormone levels in daughters of breast cancer patients and controls.
    Pike MC; Casagrande JT; Brown JB; Gerkins V; Henderson BE
    J Natl Cancer Inst; 1977 Nov; 59(5):1351-5. PubMed ID: 909096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal relations between plasma concentrations of luteinizing hormone, follicle-stimulating hormone, estradiol-17beta, progesterone, prolactin, and alpha-melanocyte-stimulating hormone during the follicular, ovulatory, and early luteal phase in the bitch.
    de Gier J; Kooistra HS; Djajadiningrat-Laanen SC; Dieleman SJ; Okkens AC
    Theriogenology; 2006 Apr; 65(7):1346-59. PubMed ID: 16197989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial serum levels of gonadotropins, prolactin and sex steroids in the nonpregnant and pregnant chimpanzee.
    Reyes FI; Winter JS; Faiman C; Hobson WC
    Endocrinology; 1975 Jun; 96(6):1447-55. PubMed ID: 1126314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal evaluation of the intrauterine progesterone contraceptive system.
    Bryand-Greenwood GD; Greenwood FC; Hale RW; Morishige WK
    J Clin Endocrinol Metab; 1977 Apr; 44(4):721-7. PubMed ID: 849982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a superactive luteinizing hormone-releasing factor agonist on gonadotropin and ovarian function during the menstrual cycle.
    Sheehan KL; Casper RF; Yen SS
    Am J Obstet Gynecol; 1979 Nov; 135(6):759-63. PubMed ID: 386801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle.
    Stanczyk FZ; Miyakawa I; Goebelsmann U
    Am J Obstet Gynecol; 1980 Jun; 137(4):443-50. PubMed ID: 7386528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of changes in glycoproteins, polypeptides, and steroids in the peritoneal fluid of women during the periovulatory phase of the menstrual cycle.
    Bouckaert PX; Evers JL; Doesburg WH; Schellekens LA; Rolland R
    J Clin Endocrinol Metab; 1986 Feb; 62(2):293-9. PubMed ID: 3079772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of hormones in the etiology of human breast cancer.
    Kirschner MA
    Cancer; 1977 Jun; 39(6 Suppl):2716-26. PubMed ID: 326377
    [No Abstract]   [Full Text] [Related]  

  • 17. [Simultaneous study of plasma gonadotropins, estrogens, progesterone and 17-hydroxyprogesterone during the ovulatory cycle].
    Roger M; Veinante A; Soldat MC; Tardy J; Tribondeau E; Scholler R
    Nouv Presse Med; 1975 Sep; 4(30):2173-8. PubMed ID: 1178478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum gonadotropin and steroid patterns during the normal menstrual cycle.
    Mishell DR; Nakamura RM; Crosignani PG; Stone S; Kharma K; Nagata Y; Thorneycroft IH
    Am J Obstet Gynecol; 1971 Sep; 111(1):60-5. PubMed ID: 5096358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism and biologic response of estrogen sulfates in hormone-dependent and hormone-independent mammary cancer cell lines. Effect of antiestrogens.
    Pasqualini JR; Gelly C; Nguyen BL
    Ann N Y Acad Sci; 1990; 595():106-16. PubMed ID: 2375600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.